Empagliflozin (Jardiance) receives SMC approval for the treatment of heart failure with reduced ejection fraction
FirstWord Pharma,
Bracknell, UK, 12 October 2021 -The Scottish Medicines Consortium (SMC) has today announced that empagliflozin (Jardiance®) has…